2.50
Hdl Handle:
http://hdl.handle.net/10541/78034
Title:
Symptom interval in young people with bone cancer.
Authors:
Goyal, Shama; Roscoe, J; Ryder, W David J; Gattamaneni, Rao; Eden, Tim O B
Abstract:
Symptom interval (SI), the time from first symptom/sign to diagnosis and initiation of treatment, appears to be principally influenced by tumour biology. Whether the age of the patient, patient delay, professional delay and access to health professionals influences the SI in bone tumours was investigated in this study. 115 patients with newly diagnosed osteosarcoma and Ewing's sarcoma were retrospectively reviewed. The median total SI for all bone tumours was 3.8 months (range 1-46 months). Patients older than 12 years had a longer SI (P = 0.05) and more patient delays (P = 0.02). Total SI and professional delays were longer if the General Practitioner was first seen compared with an Accident and Emergency Consultant (P = 0.02 and 0.02, respectively). However, SI did not influence overall and event-free survival in this series. Bone tumour patients have long SIs that are significantly affected by age and local health-care support systems. Early referral to specialists would help to alleviate anxiety and distress to the patient and family, even if currently delay does not influence outcome.
Affiliation:
Young Oncology Unit, Christie Hospital, Wilmslow Road, Manchester M20 4BX, UK.
Citation:
Symptom interval in young people with bone cancer. 2004, 40 (15):2280-6 Eur. J. Cancer
Journal:
European Journal of Cancer
Issue Date:
Oct-2004
URI:
http://hdl.handle.net/10541/78034
DOI:
10.1016/j.ejca.2004.05.017
PubMed ID:
15454254
Type:
Article
Language:
en
ISSN:
0959-8049
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorGoyal, Shama-
dc.contributor.authorRoscoe, J-
dc.contributor.authorRyder, W David J-
dc.contributor.authorGattamaneni, Rao-
dc.contributor.authorEden, Tim O B-
dc.date.accessioned2009-08-20T13:00:23Z-
dc.date.available2009-08-20T13:00:23Z-
dc.date.issued2004-10-
dc.identifier.citationSymptom interval in young people with bone cancer. 2004, 40 (15):2280-6 Eur. J. Canceren
dc.identifier.issn0959-8049-
dc.identifier.pmid15454254-
dc.identifier.doi10.1016/j.ejca.2004.05.017-
dc.identifier.urihttp://hdl.handle.net/10541/78034-
dc.description.abstractSymptom interval (SI), the time from first symptom/sign to diagnosis and initiation of treatment, appears to be principally influenced by tumour biology. Whether the age of the patient, patient delay, professional delay and access to health professionals influences the SI in bone tumours was investigated in this study. 115 patients with newly diagnosed osteosarcoma and Ewing's sarcoma were retrospectively reviewed. The median total SI for all bone tumours was 3.8 months (range 1-46 months). Patients older than 12 years had a longer SI (P = 0.05) and more patient delays (P = 0.02). Total SI and professional delays were longer if the General Practitioner was first seen compared with an Accident and Emergency Consultant (P = 0.02 and 0.02, respectively). However, SI did not influence overall and event-free survival in this series. Bone tumour patients have long SIs that are significantly affected by age and local health-care support systems. Early referral to specialists would help to alleviate anxiety and distress to the patient and family, even if currently delay does not influence outcome.en
dc.language.isoenen
dc.subjectBone Canceren
dc.subject.meshAdolescent-
dc.subject.meshAdult-
dc.subject.meshBone Neoplasms-
dc.subject.meshChild-
dc.subject.meshChild, Preschool-
dc.subject.meshEarly Diagnosis-
dc.subject.meshFamily Practice-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshMale-
dc.subject.meshOsteosarcoma-
dc.subject.meshPatient Acceptance of Health Care-
dc.subject.meshReferral and Consultation-
dc.subject.meshRetrospective Studies-
dc.subject.meshSarcoma, Ewing's-
dc.subject.meshSurvival Analysis-
dc.subject.meshTime Factors-
dc.titleSymptom interval in young people with bone cancer.en
dc.typeArticleen
dc.contributor.departmentYoung Oncology Unit, Christie Hospital, Wilmslow Road, Manchester M20 4BX, UK.en
dc.identifier.journalEuropean Journal of Canceren

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.